The Discounted Cash Flow (DCF) valuation of Intra-Cellular Therapies Inc (ITCI) is (2,944.95) USD. With the latest stock price at 75.22 USD, the upside of Intra-Cellular Therapies Inc based on DCF is -4015.1%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.2% - 7.8% | 6.5% |
| Long-term Growth Rate | 3.0% - 4.9% | 4.0% |
| Fair Price | (29,564.55) - (1,560.31) | (2,944.95) |
| Upside | -39404.1% - -2174.3% | -4015.1% |